Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.
Dalal
Hasnain
H
Lower Lemon Street Surgery, Truro TR1 2LZ. hmdalal@doctors.net.uk
Evans
Philip H
PH
Campbell
John L
JL
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003325:Coronary Care Units / Q000458:organization & administration; D003866:Depressive Disorder / Q000517:prevention & control; D005544:Forecasting; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000517:prevention & control* / Q000534:rehabilitation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D016540:Smoking Cessation
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors